img1
  • Press Release Healthcare

    Non-small cell lung cancer market projected to be worth $14.6bn by 2024, says GlobalData

    Following the recent spate of approvals in both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), the treatment landscape is becoming increasingly difficult to navigate for both physicians and patients, highlighting the need for better education, access, and infrastructure to support physicians’ and patients’ choices of the optimal therapies, says GlobalData, a...

img1
  • Press Release Healthcare

    Significant advances in diabetes medicine have been made, but many unmet needs remain, says GlobalData

    Advances in diabetes medicine, such as  anti-diabetic oral medications, incretin therapies, and novel insulin formulations have been made over the past century, but many  unmet needs remain for this complex and difficult-to-treat disease, says GlobalData, a leading data and analytics company. World Diabetes Day (14th November) aims to improve awareness of hyperglycemia (the major hallmark...

img1

Filter Media:

Reset

Media Enquiries

If you are a member of the press or media and require any further information, please get in touch, as we’re very happy to help.

Emailpr@globaldata.com
PhoneEMEA: +44 207 832 4399
PhoneAPAC: +91 40 6616 6809
Onlinecontact online

56% of #consumers are concerned about the impact of diet. Join us for more insight @incosmetics #cosmetics #trends… https://t.co/wJOJOqYIJF